Log in to save to my catalogue

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric can...

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric can...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d424ce982544f98bbf28d7feda3ba49

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

About this item

Full title

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-03, Vol.10 (1), p.1336-1336, Article 1336

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Poor infiltration of activated lymphocytes into tumors represents a fundamental factor limiting the therapeutic effect of adoptive cell immunotherapy. A tumor-penetrating peptide, iRGD, has been widely used to deliver drugs into tumor tissues. In this study, we demonstrate for the first time that iRGD could also facilitate the infiltration of lymph...

Alternative Titles

Full title

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4d424ce982544f98bbf28d7feda3ba49

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d424ce982544f98bbf28d7feda3ba49

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-09296-6

How to access this item